Drugs used for weight loss like Wegovy, Ozempic and Mounjaro are nearly everywhere in popular culture, but many patients struggling with obesity are still finding them hard to get. On today's show, what's slowing access to these drugs despite their long-term benefits for the economy and patients, and how social conditioning around obesity and excess weight clouds the conversation.
Related Episodes:
New drugs. Cheaper drugs. Why not both? (Apple / Spotify)
For sponsor-free episodes of The Indicator from Planet Money, subscribe to Planet Money+ via Apple Podcasts or at plus.npr.org.
Music by Drop Electric. Find us: TikTok, Instagram, Facebook, Newsletter.
2024-12-25 23:13164 view
2024-12-25 22:39896 view
2024-12-25 21:37258 view
2024-12-25 21:252602 view
2024-12-25 20:472681 view
2024-12-25 20:34455 view
Angelina Jolie deserves some flowers for her steady performance as Maria Callas in the biopic “Maria
Thousands of cans of Reckitt/Mead Johnson Nutrition's infant formula sold in the U.S. are being reca
DENVER (AP) — A man leaving the scene of a car wreck Tuesday shot his way into the Colorado Supreme